Qi, T., Jin, Y., Wang, H., Liao, Y., Liu, T., Mao, E., . . . Ling, Y. (2023). Nirmatrelvir‐ritonavir therapy and COVID‐19 vaccination improve clinical outcomes of SARS‐CoV‐2 Omicron variant infection. Journal of medical virology, 95(2), e28497-n/a. https://doi.org/10.1002/jmv.28497
Chicago Style (17th ed.) CitationQi, Tangkai, et al. "Nirmatrelvir‐ritonavir Therapy and COVID‐19 Vaccination Improve Clinical Outcomes of SARS‐CoV‐2 Omicron Variant Infection." Journal of Medical Virology 95, no. 2 (2023): e28497-n/a. https://doi.org/10.1002/jmv.28497.
MLA (9th ed.) CitationQi, Tangkai, et al. "Nirmatrelvir‐ritonavir Therapy and COVID‐19 Vaccination Improve Clinical Outcomes of SARS‐CoV‐2 Omicron Variant Infection." Journal of Medical Virology, vol. 95, no. 2, 2023, pp. e28497-n/a, https://doi.org/10.1002/jmv.28497.